OMEGA THERAPEUTICS INC (OMGA)
US68217N1054 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -97.43M | -102.70M | -68.28M | -29.45M | -17.95M | |||
| Depreciation Amortization | 1.57M | 1.56M | 1.39M | 1.15M | 790.00K | |||
| Change In Working Capital | -9.37M | -9.88M | 4.51M | 1.46M | 1.10M | |||
| Interest Paid | 1.72M | 1.26M | 750.00K | 730.00K | 560.00K | |||
| Other non cash items | 13.72M | 12.50M | 4.78M | 710.00K | 370.00K | |||
| OPERATING CASH FLOW | -91.51M | -98.52M | -57.61M | -26.13M | -15.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.87M | -1.38M | -1.47M | -1.81M | -890.00K | |||
| Other Investing Activity | 50.38M | -16.68M | -38.93M | N/A | N/A | |||
| INVESTING CASH FLOW | 47.52M | -18.06M | -40.40M | -1.81M | -890.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.62M | 0.00 | 8.00M | 0.00 | 4.00M | |||
| Stock Issued/Repurchased | 40.49M | 710.00K | 253.89M | 48.70M | 8.02M | |||
| Other Financing Activity | -288.00K | 0.00 | -350.00K | -80.00K | -40.00K | |||
| FINANCING CASH FLOW | 41.82M | 710.00K | 261.54M | 48.62M | 11.99M | |||
| CHANGE IN CASH | -2.17M | -115.87M | 163.53M | 20.68M | -4.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -91.51M | -98.52M | -57.61M | -26.13M | -15.68M | |||
| Capital Expenditure | -2.87M | -1.38M | -1.47M | -1.81M | -890.00K | |||
| FREE CASH FLOW | -94.38M | -99.90M | -59.08M | -27.94M | -16.57M | |||
All data in USD